Silvercrest Asset Management Group LLC Exagen Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.6 Billion
- Q4 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Exagen Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 535,017 shares of XGN stock, worth $2.26 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
535,017
Previous 540,888
1.09%
Holding current value
$2.26 Million
Previous $1.67 Million
31.24%
% of portfolio
0.02%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Rtw Investments, LP New York, NY1.51MShares$6.4 Million0.1% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$3.77 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.08 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$2.05 Million0.0% of portfolio
-
Perkins Capital Management Inc424KShares$1.79 Million1.67% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $68.8M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...